Image of Drs. Singh and Khanani on the phone discussing the findings from the GATHER2 open label extension study on avacincaptad pegol for geographic atrophy.

Avacincaptad Pegol for GA: 3-year Results from the GATHER2 Open-Label Extension Trial

In the first episode of Evidence Based Retina, Rishi P. Singh, MD, and Arshad M. Khanani, MD, MA, review data from the GATHER2 open-label extension study.

Evidence Based Retina

Astellas
Topcon Healthcare